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FIRDAUS KAMARULZAMAN, JULENAH AG NUDDIN, KAI LI LIM, AISHAH ADAM, AHMAD SAZALI HAMZAH & 
AHMAD ROHI GHAZALI
ABSTRACT
Quassia borneensis has been traditionally used as antihypertensive agent without any scientific literature on its mechanism 
of action. The objective of this study was to evaluate the antiinflammatory, antioxidant and antiproliferation properties of 
Q. borneensis extracts. The hexane, chloroform and aqueous extracts of root and bark of Q. borneensis were subjected to 
nitric oxide (NO) inhibition assay in LPS-stimulated RAW 264.7 cells. Expression of inducible NO synthase (iNOS) protein 
level was analyzed by Western blot. The antioxidant and antiproliferative activities of the extracts on HL-60 cells were 
determined using Ferric Reducing Antioxidant Power (FRAP) and MTT assays, respectively. The chloroform extract of 
Q. borneensis root obtained by soxhlet method (CSR) significantly inhibited 97.64 ± 0.96% of NO production (p < 0.001) 
and suppressed iNOS expression (p < 0.05) at the highest concentration of 1.0 µg/ml. The chloroform extract of bark 
obtained by maceration (CMB) exhibited the highest antioxidant capacity in the absence and presence of HL-60 cells, 
where the FRAP value were 125.45 ± 9.10 µM FeSO4.7H2O and 181.55 ± 3.45 µM FeSO4.7H2O, respectively. The greatest 
inhibition of HL-60 cell proliferation was exhibited by the chloroform extract of bark obtained by soxhlet method (CSB) 
with the IC
50
 of 5.0 µg/ml. The findings suggested that the chloroform extracts of Q. borneensis possess antiinflammatory, 
antioxidant and antiproliferative activities.
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ABSTRAK
Quassia borneensis telah digunakan secara tradisional sebagai agen antihipertensi tanpa sebarang kajian saintifik 
terhadap mekanisme tindakannya. Objektif kajian ini adalah untuk menilai kandungan antiinflamasi, antioksidan dan 
antiproliferasi ekstrak Q. borneensis. Ekstrak heksana, kloroform dan akueus akar dan kulit Q. borneensis dinilai 
terhadap asai perencatan nitrik oksida (NO) dalam sel RAW 264.7 terangsang LPS. Tahap pengekspresan protein inducible 
NO synthase (iNOS) dianalisa dengan pemendapan Western. Aktiviti antioksidan dan antiproliferasi ekstrak terhadap sel 
HL-60 ditentukan dengan asai Ferric Reducing Antioxidant Power (FRAP) dan MTT, masing-masing. Ekstrak kloroform 
akar dengan kaedah soxhlet (CSR) secara signifikan merencat 97.64 ± 0.96% penghasilan NO (p < 0.001) dan menindas 
ekspresi iNOS (p < 0.05) pada kepekatan tertinggi yang diuji iaitu 1.0 µg/ml. Ekstrak kloroform kulit dengan kaedah 
maserasi (CMB) mempamerkan kapasiti antioksidan tertinggi dengan ketiadaan dan kehadiran sel HL-60, dimana nilai 
FRAP adalah sebanyak 125.45 ± 9.10 µM FeSO4.7H2O dan 181.55 ± 3.45 µM FeSO4.7H2O, masing-masing. Perencatan 
terbaik terhadap proliferasi sel HL-60 dipamerkan oleh ekstrak kloroform kulit dengan kaedah soxhlet (CSB) dengan nilai 
IC
50
 5.0 µg/ml. Dapatan kajian mencadangkan bahawa ekstrak kloroform Q. borneensis mempunyai aktiviti antiinflamasi, 
antioksidan dan antiproliferasi.
Kata kunci: Quassia; Quassia borneensis; antiinflamasi; antioksidan; antiproliferasi
INTRODUCTION
One of the strategies that contributes to a high rate 
of success in finding new drug candidates is through 
ethnopharmacological survey (Fabricant & Farnsworth 
2001). For example, Quassia amara from Simaroubaceae 
family which is traditionally used as a bitter tonic, to treat 
fever and ulcers by the natives of South America was 
discovered to contain several bioactive compounds known 
as quassinoids and had scientifically shown various potent 
biological activities including anticancer and antimalarial 
properties (Bertani et al. 2006; Houel et al. 2009).
Chemical and biological research on various genera 
of the Simaroubaceae plant family such as Ailanthus, 
Brucea, Eurycoma, Simaba, Quassia and others have also 
been performed and the biological activities exerted by 
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these plant extracts were found to be contributed by the 
presence of a group of compounds known as quassinoid 
(Bhat & Karim 2010; Kundu & Laskar 2010; Lau et al. 
2005; Muhammad et al. 2004). In Sabah and Sarawak of 
East Malaysia, an indigenous plant identified as Quassia 
borneensis Noot. has been used traditionally to treat 
hypertension (Goh et al. 1995). The plant can be found 
in primary mixed dipterocarp forest and locally called as 
mamungal or pait-pait (Kulip & Wong 1995). However, 
scientific study has not been performed on this plant 
to discover its potential biological activities except for 
the antiplasmodial activity which was recently reported 
(Ghazali et al. 2013; Wan Razali et al. 2015).
Realizing the huge potentials of medicinal plants 
from the Simaroubaceae family for cancer prevention and 
treatment due to the presence of quassinoids, hence this 
study was focused on three inhibitory effects on cancer 
development. An excess production of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) at the 
site of chronic inflammation can lead to cancer. It was 
suggested that massive release of nitric oxide (NO) by 
macrophages and chemical reactions of NO with other 
radicals can generate oxidative and nitrosative stress. 
This condition will not only cause macromolecular and 
cellular damages, but also activate transcription factors 
such as nuclear factor-κB and thus promote tumor 
development through the regulation of cellular proliferation 
(Mantovani et al. 2008; Reuter et al. 2010). Therefore, 
these mechanisms are important targets for both cancer 
prevention and treatment.
The objective of this study was to evaluate the 
antiinflammatory, antioxidant and antiproliferative 
properties of Q. borneensis bark and root extracts. The 
findings of biological activities of this plant were aimed 
to scientifically document the benefits of its traditional 
application, which later will lead to the discovery of 
potential chemopreventive agent or chemotherapeutic 
drug candidate.
MATERIALS AND METHODS
CHEMICALS AND REAGENTS
Lipopolysaccharides (LPS) from Escherichia coli 055:B5, 
positive control drugs and most chemicals used were 
purchased from Sigma-Aldrich (USA). Sodium nitrite and 
2, 4, 6-Tripyridyl-s-triazine (TPTZ) were purchased from 
Merck (USA). Ferric chloride (FeCl3) was from HmBG 
Chemicals (Germany) and dimethyl sulfoxide (DMSO) was 
from Ajax Finechem (Australia). Primary and secondary 
antibodies were purchased from Cell Signaling Technology 
(USA).
PLANT’S SAMPLING AND EXTRACTION
Samples of the plant were acquired from a fully grown 
tree and identified by botanist of Forest Research Centre 
(FRC), Sepilok, Sandakan, Sabah, Malaysia. Herbarium 
specimen (SAN 152508) was prepared and deposited in 
the FRC Herbarium. Plant samples were classified to twigs, 
wood, leave, root and bark before they were processed into 
powder form and stored in a −15°C chill room. 
All chemicals used in plant extraction were of 
analytical grade from Merck (Germany). About 1 kg of 
powder form plant samples were defatted in petroleum 
ether and macerated in methanol for two days before 
concentrated in vacuo. The concentrated methanol extracts 
were suspended in 10% (v/v) aqueous methanol and 
partitioned between n-hexane and chloroform. The pooled 
extracts of hexane and chloroform were concentrated in 
vacuo producing hexane and chloroform extracts. The 
aqueous portions were freeze-dried to acquire aqueous 
extracts. These extracts were labeled as Q. borneensis 
macerated extracts. Another batch of extraction was 
carried out in soxhlet apparatus glassware for 24 h and 
the extracting procedure was followed accordingly. These 
hexane, chloroform and aqueous extracts were labeled as 
Q. borneensis soxhlet extracts. The properties of extracts 
produced were summarized in Table 1.
TABLE 1. Properties of Q. borneensis extracts tested and its antiproliferative activities on HL-60 cells after 48 h of treatment
   Sample Method Part Abbreviation IC50 (µg/ml)
 Hexane extracts Maceration Bark HMB >100
  Maceration Root HMR >100
  Soxhlet Bark HSB 42
  Soxhlet Root HSR 24
 Chloroform extracts Maceration Bark CMB 7
  Maceration Root CMR 9
  Soxhlet Bark CSB 5
  Soxhlet Root CSR 6
 Aqueous extracts Maceration Bark AMB 6
  Maceration Root AMR >100
  Soxhlet Bark ASB >100
  Soxhlet Root ASR 19
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CELL CULTURE
Human promyelocytic leukemia HL-60 (ATCC® CCL-240™) 
and murine monocytic macrophage RAW 264.7 (ATCC® 
TIB-71™) cells were obtained from American Type Culture 
Collection (Rockville, USA). HL-60 cells were grown in 
Iscove’s Modified Dulbecco’s Medium (Sigma, USA) with 
20% (v/v) fetal bovine serum (FBS) (JR Scientific, USA). 
RAW 26.7 cells were grown in Dulbecco’s Modified Eagle 
Medium (Gibco, Invitrogen, USA) with 10% FBS. Both 
culture media were supplemented with 1% (v/v) penicillin/
streptomycin (PAA, Austria) and cells were maintained at 37 
°C in 5% CO2. The number of viable cells was determined 
by the trypan blue dye exclusion with a hemocytometer.
DETERMINATION OF NITRIC OXIDE PRODUCTION
Murine macrophage RAW 264.7 cells (1 × 105 cells/ml) 
were seeded in 96-well plate overnight and treated with 
0.125−1.0 µg/ml Q. borneensis extracts for 2 h before 
LPS (1 µg/ml) was added. After 24 h treatment with Q. 
borneensis extracts at 37°C and 5% CO2, production of 
nitrite, the stable conversion product of nitric oxide was 
determined by Griess assay (Green et al. 1982). Briefly, 
100 µl of culture media was transferred to another 96-
well plate and mixed with 100 µl of Griess reagent (1% 
sulfanilamide, 0.1% naphthalenediamine dihydrochloride) 
and incubated for 10 min at room temperature in dark. 
Color development was read at 570 nm by microplate 
reader (Bio-Rad, USA). Sodium nitrite (0–100 µM) was 
used to generate the standard curve. Indomethacin, the 
non-steroidal antiinflammatory drug was used as positive 
control. Cytotoxic effect of the extracts on RAW 264.7 cells 
was determined using MTT assay (Mosmann 1983) before 
the experiment conducted.
WESTERN BLOT ANALYSIS
RAW 264.7 (1 × 105 cells/ml) cells were treated with CSR 
chloroform extract at concentration of 0.125−1.0 µg/ml in 
100 mm culture dish for 2 h and then stimulated with LPS 
(1 µg/ml). After 24 h incubation, cells were harvested and 
lysed in RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 
mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% 
SDS, phosphatase and protease inhibitors). After boiling 
for 5 min, the protein samples (20 µg) were separated 
by SDS-PAGE on 12% resolving gel and transferred onto 
polyvinylidene fluoride membranes. The membranes 
were blocked with 5% skimmed-milk for 1 h and then 
incubated with iNOS antibody (1:5000) or β-actin antibody 
(1:10000) overnight at 4°C. Primary antibodies were 
removed by washing the membranes three times in TBST 
and then the membranes were incubated for 1 h with 
horseradish peroxidase conjugated secondary antibody 
(Xie 2001). Detection was performed using enhanced 
chemiluminescence reagent (Amersham™ ECL™ Select, 
GE Healthcare, UK) and images were analyzed using 
Fusion-Capt Advance (Fusion FX7, Vilber Lourmat, 
Germany).
MEASUREMENT OF ANTIOXIDANT CAPACITY
The Ferric Reducing Antioxidant Power (FRAP) assay was 
carried out to determine the antioxidant capacity of various 
extracts of Q. borneensis with slight modifications from 
Benzie & Strain (1996). The assay was performed in the 
presence and absence of cells as described by Hasiah et 
al. (2011). Concentration of Q. borneensis extracts tested 
was 6.25–100 µg/ml. In the presence of cells, HL-60 cells 
(2 × 105 cells/ml) were seeded in 96-well plate and treated 
with various concentrations of extract at 37°C and 5% CO2. 
After 2 h incubation, the plate was sonicated for 30 seconds. 
Then, freshly prepared FRAP reagent (300 mM acetate 
buffer, pH 3.6, 20 mM FeCl3, 10 mM TPTZ) was added and 
the plate was incubated for 5 min in dark. The absorbance 
at 595 nm was measured by microplate reader (Bio-Rad, 
USA). FeSO4.7H2O solution (100–1000 µM) was used to 
generate calibration curve and 100 µM L-ascorbic acid was 
used as positive control. The antioxidant capacity of the 
sample was calculated using the FeSO4·7H2O calibration 
curve and expressed as FRAP value (µM FeSO4·7H2O 
equivalent).
CELL PROLIFERATION ASSAY
Antiproliferative activity of Q. borneensis towards HL-60 
cells was determined from its viability percentage by MTT 
assay (Mosmann 1983). The concentration of Q. borneensis 
extracts tested was 6.25–100 µg/ml. Briefly, HL-60 cells 
(2 × 105 cells/ml) were seeded and treated with various 
concentrations of Q. borneensis extracts for 48 h at 37°C 
in 5% CO2. Then, 20 µl of freshly prepared MTT (3-(4, 
5-dimethylthiazol-2-yl)-2-5-diphenyl tetrazolium bromide) 
solution (5 mg/ml) was added into each well in dark. The 
culture plate was then incubated for another 4 h and the 
formazan crystal formed was dissolved with DMSO. The 
plate was incubated for 15 min and shaken for 5 min using 
vortex mixture. Absorbance at 570 nm was measured using 
microplate reader (Bio-Rad, USA). Etoposide was used 
as positive control. The percentage of cell viability was 
calculated by dividing the sample absorbance with negative 
control absorbance and multiplied by 100%.
STATISTICAL ANALYSIS
The results were expressed in mean ± SD from three 
independent experiments. Graphs were constructed with 
SEM error bars. The data were analyzed using Statistical 
Package for the Social Sciences (SPSS) software version 20. 
Differences in mean values between groups were analyzed 
by one-way ANOVA followed by post-hoc test. Statistical 
significant was considered at p < 0.05.
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RESULTS
ANTIINFLAMMATORY ACTIVITIES OF Q. borneensis 
EXTRACTS
Quassia borneensis hexane, chloroform and aqueous 
extracts showed different degrees of cytotoxicity to 
RAW 264.7 cells. For the screening purpose, the highest 
treatment concentration of 1 µg/ml was chosen for all 
extracts because it was able to maintain more than 85% 
of cell viability after 24 h incubation as measured by 
MTT assay. Concentration of NO2
– in culture medium was 
converted into percentage over control (LPS only).
All the hexane, chloroform and aqueous extracts of Q. 
borneensis showed significant antiinflammatory activity 
following 2 h pretreatment before LPS induction except 
CMR and ASB extracts (Figure 1). The best inhibitory effects 
of NO production in LPS-stimulated RAW 264.7 cells was 
shown by CSR extract which significantly reduced 97.64 ± 
0.96% of NO production. Good antiinflammatory activity 
was also shown by CMB and CSB extracts which inhibited 
NO by 51.16 ± 2.01 and 61.02 ± 6.58%, respectively. Among 
hexane extracts, HMB and HSB extracts showed a marked 
inhibitory effect with 34.82 ± 8.54 and 32.55 ± 10.2% 
reduction of NO production, respectively. Other extracts 
give less than 25% of NO inhibition. Indomethacin as a 
positive control significantly inhibited the NO production 
by 45.12 ± 2.67%.
When tested at several concentrations ranging from 
0.125 to 1.0 µg/ml, CSR extract showed dose-dependent 
inhibitory effect on NO production (Figure 2). Western blot 
analysis demonstrated that the extract was able to suppress 
iNOS expression at higher concentration (Figure 3). A slight 
increase in iNOS expression was detected at lower treatment 
concentration of CSR extract, but was not significantly 
different compared to the negative control (p > 0.05).
FIGURE 1. Effect of Q. borneensis extracts on NO production in LPS-stimulated RAW 264.7 macrophages for 24 h. Cells were 
treated with extracts at 1 µg/ml and Indomethacin (IDM) at 100 µM. *p < 0.05; **p < 0.01; ***p < 0.001 compared to control (C). 
Abbreviation of extracts–H: hexane; C: chloroform; A: aqueous; M: maceration; S: soxhlet; B: bark; R: root
FIGURE 2. Effect of the Q. borneensis chloroform soxhlet root (CSR) extract on NO production in LPS-stimulated RAW 264.7 
macrophages for 24 h. *p < 0.05; **p < 0.01; ***p < 0.001 compared to control (C)
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ANTIOXIDANT ACTIVITIES OF Q. borneensis EXTRACTS
The antioxidant activity of Q. borneensis extracts were 
determined by FRAP assay which measures the ability of a 
substance to reduce ferric to ferrous ions. The assay was 
performed in two conditions; extracts only and extracts 
incubated with cells. Chloroform extracts demonstrated 
high antioxidant capacity, followed by aqueous extracts 
(Figure 4). The highest FRAP value obtained was given by 
the CMB extract (181.55 ± 5.98), while the lowest value 
was given by HMB extract (4.20 ± 0.07). On the other 
hand, untreated HL-60 cells only produce FRAP value of 
0.62 ± 1.32 μM FeSO4·7H2O. After 2 h incubation with 
Q. borneensis extracts, a significant increase (p < 0.05) 
was observed in the antioxidant capacity for all extracts 
treatment. Although hexane extracts alone showed low 
antioxidant activity, but HMB, HMR, HSB and HSR extracts 
were able to increase cellular antioxidant value with 7.6, 
6.2, 10.9 and 4.1 times higher, respectively, when incubated 
with HL-60 cells. Treatment with AMR aqueous extract 
also showed 6.7 times significant increase of cellular 
antioxidant activity of HL-60 cells.
ANTIPROLIFERATIVE ACTIVITIES OF Q. borneensis EXTRACTS
After 48 h of treatment, the IC50 value which corresponded 
to the concentration of test substance resulting in a 50% 
inhibition of cell growth, was determined from the graph 
of percentage of cell viability versus concentration. All 
chloroform extracts exhibited the greatest degree of 
antiproliferative activity on HL-60 cells with the IC50 value 
< 10 µg/ml (Table 1). Surprisingly, AMB aqueous extract 
also demonstrated a significant activity as chloroform 
extracts. In addition, ASR aqueous extract showed better 
inhibition of HL-60 cell proliferation than HSR and HSB 
hexane extracts based on the IC50 value obtained. Other 
extracts were less effective because no IC50 recorded within 
the range of treatment concentration. Etoposide was used 
as positive control and inhibited HL-60 cell proliferation 
with IC50 value of 2.4 µg/ml (4 µM).
DISCUSSION
Inhibition of NO production and suppression of its 
molecular pathway is one of the target mechanisms for 
cancer prevention (Hofseth 2008). In the study, the hexane, 
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FIGURE 3. Effect of chloroform soxhlet root (CSR) extract of Q. borneensis and Indomethacin (IDM) (100 µM) on (a) iNOS protein 
expression in LPS-stimulated RAW 264.7 macrophages from Western blot analysis (top) and fold difference in relative iNOS protein 
band intensities that were quantified by densitometry (bottom). *p < 0.05; **p < 0.01 as compared to control (C)
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chloroform and aqueous extracts from bark and root of Q. 
borneensis were screened for NO inhibitory effects and the 
most prominent activity was shown by chloroform extract 
of Q. borneensis root obtained by the Soxhlet method. 
During the inflammatory responses, NO production was 
mediated by the inducible nitric oxide synthase (iNOS). 
This enzyme was not constitutively expressed under 
physiological condition, but can be stimulated by pro-
inflammatory stimuli such as LPS, TNF-α and IFN-γ (Masini 
et al. 2010). It was evident from our results that inhibition of 
NO production in macrophage by Q. borneensis chloroform 
root extract was also due to the suppression of iNOS protein 
expression. 
Several plants from Simaroubaceae family have 
been shown to have anti-inflammatory properties. For 
example, Q. amara extracts showed significant inhibition 
of iNOS and COX-2 protein through prevention of nuclear 
translocation of NF-κB (Verma et al. 2009). Studies on 
chemical constituent has identified that few quassinoids 
such as bruceines B and bruceines E from B. javanica 
(Liu et al. 2012) and ailanthone from A. altissima (Kim 
et al. 2015) displayed an active inhibitory effects on NO 
production. However, β-carbolines alkaloids isolated from 
P. quassioides were contributed to the antiinflammatory 
activities of the plant extract (Jiao et al. 2011). Therefore, 
chemical studies on is needed to elucidate the potential 
constituents that give the antiinflammarory effects of Q. 
borneensis extracts. 
The Q. borneensis extracts also showed antioxidant 
activities by two possible mechanisms. Direct measurement 
of the extracts’ antioxidant capacity indicated the chemical 
structure and reaction of an antioxidant. On the contrary, 
co-incubation of the extracts with cells represented the 
biological activity of an antioxidant. The use of cell-
based assay was introduced by Wolfe & Liu (2007) using 
dichlorofluorescin oxidation to measure cellular antioxidant 
activity. However, measurement of Fe2+ to Fe3+ conversion 
was employed for both conditions in this study to determine 
the antioxidant properties of Q. borneensis extracts. All 
extracts demonstrated an increase in antioxidant capacity 
when incubated with cells compared to the extracts alone. 
This could be due to the increase in cellular antioxidant 
because untreated cells showed almost no activity (0.62 
μM FeSO4·7H2O). The presence of high polyphenolic 
content in plant extracts was known to possess antioxidant 
properties and can be extracted with polar organic solvents 
(Ablat et al. 2013; Dai & Mumper 2010). This could be 
the explanation of higher antioxidant activities shown by 
Q. borneensis chloroform extracts.
It was known that an excess production of reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) 
play important role in cancer development. At the site of 
inflammation, respiratory burst caused massive release 
of ROS such as superoxide anions (O2
−) and hydrogen 
peroxide (H2O2). NO is chemically unreactive, but can 
react with these molecules and produce a powerful 
oxidant, peroxynitrite (ONOO−), nitrogen dioxide (NO2) 
and nitrogen trioxide (N2O3). Damage to surrounding 
tissues cause by these radical molecules will trigger more 
infiltration of inflammatory cells and activate signaling 
pathway linked to inflammation and cell proliferation 
such as NF-κB. In turn, NF-κB activation will lead to 
FIGURE 4. Antioxidant capacity of Q. borneensis extracts alone and in the presence of HL-60 cells at concentration 100 µg/ml.  
*p < 0.05 represent significant different of FRAP value extract + HL-60 cells compared to extract only.
Abbreviation of extracts–H: hexane; C: chloroform; A: aqueous; M: maceration; S: soxhlet; B: bark; R: root
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upregulation of iNOS expression and therefore producing 
more NO (Reuter et al. 2010).
In addition, Q. borneensis extracts specifically the 
chloroform extracts demonstrated good antiproliferative 
activity towards HL-60 cells. The cytotoxic and inhibition 
of cell proliferation properties of many Simaroubaceae 
plants have been extensively studied and linked to the 
presence of specific quassinoids. For example, several 
quassinoids have been isolated from Q. amara leaf extracts, 
however only the simalikalactone D gave a significant 
cytotoxic activity (Houel et al. 2009). The bioactive 
composition was still not determined in our study, but it 
is expected that quassinoid contributed to the inhibition of 
HL-60 cell proliferation as that compound was known for 
its antileukemic effects (Hitotsuyanagi et al. 2006). 
Findings of this study suggest that Q. borneensis 
is a valuable medicinal plant with the potential as a 
source of chemopreventive agent which could be based 
on its antiinflammatory and antioxidant properties. Q. 
borneensis can also be further studied to search for 
a new chemotherapeutic candidate due to its potent 
antiproliferative activity of the chloroform extracts. 
Recently, Ag Nuddin et al. (2015) had reported the presence 
of canthin-6-one alkaloid and five quassinoids which were 
identified as glaucarubolone, chaparrinone, holacanthone, 
glaucarubinone and ailanthinone in this species. Although 
quassinoids are known for its antileukemic and antimalarial 
activities, determination of chemopreventive and/or 
chemotherapeutic activities of these compounds will then 
explain the medicinal properties of Q. borneensis and the 
mechanism of action involved at the cellular and molecular 
levels.
CONCLUSION
Q. borneensis extracts particularly the chloroform extracts 
possess antiinflammatory, antioxidant and antiproliferative 
properties. Our scientific findings would provide basic 
information for its medicinal purposes. However, the 
characterization of the bioactive constituents which include 
the quassinoid is still needed to discover its therapeutic 
potential.
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